ripekg:evaluation/RIPEA91FDCB2559E7F9DD |
prov:used |
ripekg:study-design-evidence/RIPEA91FDCB2559E7F9DD |
ripekg:study-design-evidence/RIPEA91FDCB2559E7F9DD |
rdf:type |
rdfs:Resource |
ripekg:study-design-evidence/RIPEA91FDCB2559E7F9DD |
rdf:type |
owl:Thing |
ripekg:study-design-evidence/RIPEA91FDCB2559E7F9DD |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:study-design-evidence/RIPEA91FDCB2559E7F9DD |
rdf:type |
ripe:StudyDesignEvidenceStudy design evidence |
ripekg:study-design-evidence/RIPEA91FDCB2559E7F9DD |
rdf:type |
tido:Evidence |
ripekg:study-design-evidence/RIPEA91FDCB2559E7F9DD |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA91FDCB2559E7F9DD |
ripekg:study-design-evidence/RIPEA91FDCB2559E7F9DD |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA91FDCB2559E7F9DD |
ripekg:study-design-evidence/RIPEA91FDCB2559E7F9DD |
ripe:concerns |
ripekg:work/10.1038%2Fs41591-026-04253-5AI-based chest X-ray prioritization in the lung cancer diagnostic pathway: the LungIMPACT randomized controlled trial |
ripekg:study-design-evidence/RIPEA91FDCB2559E7F9DD |
ripe:recruitmentEndDate |
31-12-2024 |
ripekg:study-design-evidence/RIPEA91FDCB2559E7F9DD |
ripe:recruitmentEndDateExtractionRationale |
Results: 'Between 17 July 2023 and 31 December 2024, a total of 97,731 CXRs were performed'. |
ripekg:study-design-evidence/RIPEA91FDCB2559E7F9DD |
ripe:recruitmentStartDate |
17-07-2023 |
ripekg:study-design-evidence/RIPEA91FDCB2559E7F9DD |
ripe:recruitmentStartDateExtractionRationale |
Results: 'Between 17 July 2023 and 31 December 2024, a total of 97,731 CXRs were performed'. |
ripekg:study-design-evidence/RIPEA91FDCB2559E7F9DD |
ripe:studyEndDate |
05-06-2025 |
ripekg:study-design-evidence/RIPEA91FDCB2559E7F9DD |
ripe:studyEndDateExtractionRationale |
Results: 'Patients were followed up until 5 June 2025'. Used as fallback for study end per rule 4. |
ripekg:study-design-evidence/RIPEA91FDCB2559E7F9DD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA91FDCB2559E7F9DD-human-2-2 |
ripekg:study-design-evidence/RIPEA91FDCB2559E7F9DD |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA91FDCB2559E7F9DD-inspectai-2-2 |